|
|
|
|
|
|
|
|
|
|
|
About Us : Executive Council |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chairman, Dr Michael Entzeroth |
|
|
|
|
|
Dr. Michael Entzeroth is the Senior Vice
President, Drug Discovery, of the A*STAR Experimental
Therapeutic Centre. He has extensive experience in the
pharmaceutical industry, with many success records in drug
discovery and development. Dr. Entzeroth is combining his
exceptional technical knowledge with his strong business
acumen. He possesses an ability to generate entrepreneurial
drug discovery cultures in multicultural environments.
Dr. Michael
Entzeroth is the founder and Managing Director of Pharma
Resources Asia Pte Ltd, Singapore.
Previously, he was Chief Scientific Officer of S*BIO Pte Ltd
in Singapore and Vice President of
CEREP SA in France where he was
a member of the Executive Management Committee and responsible
for the company’s pharmacology service and discovery
activities. From 1985 to 1999, he was with Boehringer
Ingelheim Germany responsible
for a variety of drug discovery programs and held finally the
position of Head of High Throughput Screening.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 Back to
top
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Honorary Secretary, Priyadarshini
Rath
|
|
|
|
|
|
 Priya is currently pursuing her MBA at
INSEAD. Prior to business school,
Priya was an Assistant Vice President at Exploit Technologies,
the marketing and commercialization arm of A*STAR (Agency for
Science Technology and Research), where she oversaw A*STAR’s
biomedical patent portfolio. Prior to Exploit
Technologies, Priya held positions of increasing
responsibility at Ella Cheong Spruson & Ferguson (S.E.
Asia’s largest intellectual property boutique), Affymetrix
Inc. and BioEnterprise Asia. At Ella Cheong Spruson and
Ferguson,
Priya was instrumental in growing the firm’s local biotech
clientele, and managing the firm’s Indian patent
practice. At Affymetrix Inc., Priya
successfully registered as a US patent agent and
drafted and prosecuted complex inventions before the United
States Patent and Trademark Office.
At BioEnterprise Asia, Priya was an integral member of
the team that successfully incubated Lynk Biotechnologies,
Singapore
’s first privately-funded biotech
startup.
Priya received her Masters in
Developmental Neurobiology, and Bachelors with 1st Class Honours in Cell &
Molecular Biology, both from the National University of
Singapore.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Back to
top |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Honorary Treasurer, Mr Krish
Gopalakrishnan |
|
|
|
|
|
Krish Gopalakrishnan has over 21 years
experience in the management of technology, innovation and
markets: He has been a Director in large multinational
companies as well as small start-ups and led strategy and marketing in markets
totalling ~USD 200 million. Krish has managed P&L, sales and marketing
and operations across Asia-Pacific (particularly
China, ASEAN and India) and
has managed business development in Latin
America, Russia + CIS, and the
Middle
East.
In 2005, Krish established Jeiva
International Pte. Ltd. in Singapore. Jeiva is
a boutique consulting firm which has consulted for start-ups
and leading global companies in various
fields.
He
is a lecturer at the Malaysian Institute of Management,
Kuala Lumpur,
Malaysia and
teaches Technology Commercialisation as part of a Certified
Professional Course offered at MIM. Previously Krish has been
a member of the management of several Malaysian and Indian
Bioscience
companies.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Back to
top |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Council
Member, Dr Yvette Flanigan |
|
|
|
|
|
Yvette is a Senior Patent Associate at the
Intellectual Property Department of the firm Yu Sarn Audrey &
Partners and is involved in Intellectual property drafting
registration and prosecution work. Prior to joining Yu Sarn Audrey
& Partners Yvette was a senior manager of the Intellectual
Property Management division of Exploit Technologies Pte Ltd (ETPL),
dealing with transfer of leading-edge technologies from the
Biomedical Sciences Institutes.
Yvette was previously a Biotechnology
consultant with Rajah & Tann, one of the leading law firms in
Singapore. She was part
of a team that established an IP, Technology, Entertainment and
Communications practice group for the firm. Prior to branching into
IP law she has worked as a Research Scientist at Dupont Singapore;
at the National University of Singapore (NUS); Nanyang Technological
University (NTU); and at the University of Queensland, Australia as
well as a short project at Research School of Biological Sciences,
Australia National University (ANU).
Yvette received her Ph.D. in Biochemistry from
the University of
Queensland and her Graduation
Certificate in Intellectual Property Law from the National
University of Singapore. She was awarded a certificate in patent
drafting by the Southeast Asian Drafting Patents Board of FICPI. |
|
|
| |
|
|
|
|
|
|
|
Back to
top |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Council Member, Gianfranco
Matteucci |
|
|
|
|
|
 Mr Gianfranco
Matteucci is a partner at Lloyd Wise. He is a
registered Singapore patent
agent, as well as a qualified European and Italian patent and
trademark attorney. He specialises in the fields of
biotechnology, chemistry, pharmaceuticals, plant varieties,
biomedical devices, nanotechnology and composite
materials.
Gianfranco graduated with a M.Sc. in
Biology (Laurea in Biology) from the University of Rome,
Italy. Before practicing as a patent attorney, he conducted
research in the field of cholesterol metabolism for about five
years at the University of Rome and was involved in
preclinical toxicology studies in a private company for about
two years thereafter. After obtaining a Masters in
Intellectual Property Law, Gianfranco practiced as a patent
attorney in Italy for seven
years, representing pharmaceutical, chemical and
biotechnological companies. He then spent five years in
Japan working for
the Intellectual Property department of RIKEN, a government
funded research institute, with the main working language
being Japanese. He joined the Singapore
office of Lloyd Wise (www.lloydwise.com) in July 2003, and he
has been working in Singapore since
then, representing local universities, research institutes and
companies in the chemical and biotech patent field.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Back to
top |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Council Member, Dr Andrew
Powell |
|
|
|
|
|
Dr. Powell graduated from the University of
Edinburgh with honours
in Biology and obtained his Ph.D. from the University of
Calgary, Canada. He has held research and academic positions
at the University of Guelph, Canada, the National Institute
for Health Sciences in Tokyo, and Tsukuba, Japan and the
National University of Singapore. He has worked as a
consultant since 1994 assisting a wide range of clients (MNCs,
SMEs, development agencies and governments) in their
activities in biotechnology across East Asia.
He has
considerable experience in stakeholder dialogues,
facilitations and public fora across the region and
Australia, and is
invited regularly to chair conference sessions at global
technology conferences.
He is on the organizing committee for the
Agricultural Biotechnology International Conference 2006 in
Melbourne
and also represents the World Life Science Forum (Lyon) in
Asia. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Back to
top |
|
|
|
|
|
|
|
|
|
|
|
|
